In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

抗体 亲和力成熟 细胞因子 生物 受体 体外 体细胞突变 免疫系统 免疫学 分子生物学 细胞生物学 B细胞 生物化学
作者
Stefan Steidl,Olaf Ratsch,Bodo Brocks,Manuela Dürr,Elisabeth Thomassen-Wolf
出处
期刊:Molecular Immunology [Elsevier]
卷期号:46 (1): 135-144 被引量:85
标识
DOI:10.1016/j.molimm.2008.07.013
摘要

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a KD of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the interaction of GM-CSF with the GM-CSF receptor alpha chain. As a consequence this leads to a blockade in signal transduction as measured by abolished STAT5 phosphorylation in the presence of GM-CSF and antibody. Due to its pro-inflammatory role GM-CSF has been implicated in the pathophysiology of inflammatory diseases like rheumatoid arthritis or asthma. Based on the mode of action described herein MOR04357 shows favourable antibody features as a potential drug candidate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研狗发布了新的文献求助10
刚刚
jinxuan完成签到,获得积分20
1秒前
小毛驴完成签到,获得积分10
1秒前
1秒前
酷波er应助细心青烟采纳,获得10
1秒前
3秒前
皇帝的床帘应助cc采纳,获得30
3秒前
HMZ完成签到,获得积分10
3秒前
koko完成签到,获得积分10
4秒前
XieQinxie完成签到,获得积分10
4秒前
小桑桑完成签到,获得积分10
4秒前
MOON完成签到,获得积分10
5秒前
CC完成签到,获得积分10
5秒前
一朵云完成签到,获得积分10
6秒前
Erin完成签到 ,获得积分10
6秒前
Lei完成签到,获得积分10
6秒前
搜集达人应助研友_Z11ONZ采纳,获得10
7秒前
DamonFri发布了新的文献求助10
7秒前
xiaoyu完成签到,获得积分10
7秒前
8秒前
8秒前
鲤鱼完成签到,获得积分10
8秒前
8秒前
炼金术士完成签到,获得积分10
8秒前
称心鸵鸟完成签到,获得积分10
9秒前
在水一方应助ShujunOvO采纳,获得10
10秒前
10秒前
蔡雨岑完成签到,获得积分10
11秒前
花火发布了新的文献求助30
11秒前
小六完成签到,获得积分20
11秒前
无私书雪完成签到,获得积分10
13秒前
13秒前
本草石之寒温完成签到 ,获得积分10
14秒前
xiuxiu发布了新的文献求助10
14秒前
蔡雨岑发布了新的文献求助100
14秒前
传奇3应助LZY采纳,获得10
15秒前
fan完成签到,获得积分10
15秒前
vera完成签到,获得积分10
15秒前
16秒前
rover完成签到 ,获得积分10
16秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
安全防范技术与工程 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2024 Medicinal Chemistry Reviews 400
Актуализированная стратиграфическая схема триасовых отложений Прикаспийского региона. Объяснительная записка 360
Dictionary of socialism 350
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3192935
求助须知:如何正确求助?哪些是违规求助? 2841978
关于积分的说明 8036528
捐赠科研通 2505759
什么是DOI,文献DOI怎么找? 1338749
科研通“疑难数据库(出版商)”最低求助积分说明 638486
邀请新用户注册赠送积分活动 606990